BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33741347)

  • 1. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.
    Buccoliero AM; Caporalini C; Scagnet M; Baroni G; Moscardi S; Mussa F; Giordano F; Sardi I; Genitori L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):147-154. PubMed ID: 28777153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
    Hasselblatt M; Thomas C; Hovestadt V; Schrimpf D; Johann P; Bens S; Oyen F; Peetz-Dienhart S; Crede Y; Wefers A; Vogel H; Riemenschneider MJ; Antonelli M; Giangaspero F; Bernardo MC; Giannini C; Ud Din N; Perry A; Keyvani K; van Landeghem F; Sumerauer D; Hauser P; Capper D; Korshunov A; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Kool M
    Acta Neuropathol; 2016 Jul; 132(1):149-51. PubMed ID: 27067307
    [No Abstract]   [Full Text] [Related]  

  • 5. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
    Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
    Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature].
    Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
    Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
    Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poorly-differentiated chordoma with INI1 loss: a clinicopathologic study].
    Feng JY; Chen L; Ma YY; Yang HW; Chen L
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):695-698. PubMed ID: 29050071
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas.
    Yadav R; Sharma MC; Malgulwar PB; Pathak P; Sigamani E; Suri V; Sarkar C; Kumar A; Singh M; Sharma BS; Garg A; Bakhshi S; Faruq M
    Neuro Oncol; 2014 Mar; 16(3):372-81. PubMed ID: 24305715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reclassification of rhabdoid tumor and pediatric undifferentiated/unclassified sarcoma with complete loss of SMARCB1/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features.
    Kohashi K; Tanaka Y; Kishimoto H; Yamamoto H; Yamada Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2016 Oct; 29(10):1232-42. PubMed ID: 27338635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
    Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
    Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
    Oakley GJ; Fuhrer K; Seethala RR
    Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.